Phenazine

Phenazine

SCHEMBL2873102

COS(=O)(=O)O.c1ccc2nc3ccccc3nc2c1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of Phenazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.50
NQO2 P16083 7/20 0.48
ALDH1A1 P00352 6/20 0.45
POLB P06746 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MEN1 O00255 2/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
KMT2A Q03164 2/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenazine SCHEMBL94396 1.00 MAPT (0.50) MAPTNQO2ALDH1A1POLBSMN1; SMN2
Phenazine SCHEMBL10876543 1.00 MAPT (0.50) MAPTNQO2ALDH1A1POLBSMN1; SMN2
Acridine SCHEMBL2823221 0.88 ALDH1A1 (0.58) MAPTNQO2ALDH1A1POLBSMN1; SMN2
Phenazine SCHEMBL22631548 0.86 MAPT (0.55) MAPTNQO2ALDH1A1POLBSMN1; SMN2
Phenazine SCHEMBL7095188 0.85 MAPT (0.44) MAPTNQO2ALDH1A1POLBSMN1; SMN2
SCHEMBL9602629 0.84 MEN1 (0.46) MAPTNQO2ALDH1A1POLBSMN1; SMN2
SCHEMBL997540 0.84 NQO2 (0.49) MAPTNQO2ALDH1A1POLBSMN1; SMN2
SCHEMBL31031113 0.84 NQO2 (0.49) MAPTNQO2ALDH1A1POLBSMN1; SMN2
SCHEMBL3129032 0.84 NQO2 (0.49) MAPTNQO2ALDH1A1POLBSMN1; SMN2
SCHEMBL4063489 0.84 KMT2A (0.47) MAPTNQO2ALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246485-A1 HISTAMINE MEASUREMENT METHOD AND KIT KIKKOMAN CORPORATION (JP) 2021-08-12 US claimed
US-10871484-B2 Enzymatic method for detecting polyaromatic hydrocarbons BIOO SCIENTIFIC CORPORATION (US) 2020-12-22 US claimed
WO-2020040113-A1 HISTAMINE MEASUREMENT METHOD AND KIT キッコーマン株式会社 2020-02-27 WO claimed
CN-109762871-A A kind of mixture by single sulfonic acid tetrazolium and PMS derivative is used for the purposes and its detection method of microorganism detection 杭州健昵福生物科技有限公司 2019-05-17 CN claimed
EP-2762883-B1 METHOD FOR DETERMINING COLOR CHANGE IN OXIDATION-REDUCTION INDICATOR ARKRAY INC (JP) 2019-04-17 EP claimed
US-9598715-B2 Method for measuring color change of oxidation-reduction indicator ARKRAY, INC. (JP) 2017-03-21 US claimed
US-20160054230-A1 ENZYMATIC METHOD FOR DETECTING POLYAROMATIC HYDROCARBONS PERKINELMER U.S. LLC 2016-02-25 US claimed
US-20140322749-A1 Method for Measuring Color Change of Oxidation-Reduction Indicator ARKRAY, INC. (JP) 2014-10-30 US claimed
EP-2762883-A1 METHOD FOR DETERMINING COLOR CHANGE IN OXIDATION-REDUCTION INDICATOR Arkray, Inc. (JP) 2014-08-06 EP claimed
EP-1199560-B1 Electrochemical method for the determination of the cell count and the biological activity DECHEMA (DE) 2009-09-09 EP claimed
EP-1472363-A4 METHOD AND TEST STRIPS FOR THE MEASUREMENT OF FAT LOSS DURING WEIGHT LOSS PROGRAMS GUPTA SURENDRA K (US) 2008-05-28 EP claimed
EP-1472363-A2 METHOD AND TEST STRIPS FOR THE MEASUREMENT OF FAT LOSS DURING WEIGHT LOSS PROGRAMS GUPTA, Surendra K. (US) 2004-11-03 EP claimed
WO-2003065875-A2 METHOD AND TEST STRIPS FOR THE MEASUREMENT OF FAT LOSS DURING WEIGHT LOSS PROGRAMS GUPTA SURENDRA K (US) 2003-08-14 WO claimed
US-5036000-A Threshold color control system ENZYMATICS, INC. (US) 1991-07-30 US claimed
US-12565672-B2 Sampling method and kit for histamine measurement KIKKOMAN CORPORATION (JP) 2026-03-03 US disclosed
EP-3842804-B1 SAMPLING METHOD AND KIT FOR HISTAMINE MEASUREMENT KIKKOMAN CORP (JP) 2025-01-22 EP disclosed
WO-2024090965-A1 CAPSULE FOR CONTROLLED-RELEASE INSECTICIDE AND CONTROLLED-RELEASE INSECTICIDE CONTAINING SAME 주식회사 엘지화학 2024-05-02 WO disclosed
US-4086142-A Decarboxylation of endogenous serum glutamate in transaminase assays THE DOW CHEMICAL COMPANY (US) 1978-04-25 US disclosed
US-4024021-A MIXING AMMONIA-FREE REAGENT THE DOW CHEMICAL COMPANY (US) 1977-05-17 US disclosed
US-4001089-A METHOD FOR DETERMINATION OF TRIGLYCERIDES AND GLYCEROL THE DOW CHEMICAL COMPANY (US) 1977-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246485-A1 HISTAMINE MEASUREMENT METHOD AND KIT HRH2, KIT, HRH3 MAPT 4628/4885NQO2 838/4885ALDH1A1 648/4885
US-12565672-B2 Sampling method and kit for histamine measurement HNMT, CMA1, KIT MAPT 3279/4885NQO2 2387/4885ALDH1A1 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.